Back
OpGen, Inc. 10K Form
Buy
63
OPGN
OpGen, Inc.
Last Price:
$15.7000
Seasonality Move:
-13.59%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-14 | 10Q | OPGN/OpGen, Inc. Quarterly |
| 2023-08-14 | 10Q | OPGN/OpGen, Inc. Quarterly |
| 2023-05-15 | 10Q | OPGN/OpGen, Inc. Quarterly |
| 2022-11-14 | 10Q | OPGN/OpGen, Inc. Quarterly |
| 2022-08-12 | 10Q | OPGN/OpGen, Inc. Quarterly |
| 2022-05-13 | 10Q | OPGN/OpGen, Inc. Quarterly |
Receive OPGN News And Ratings
See the #1 stock for the next 7 days that we like better than OPGN
OPGN Financial Statistics
Sales & Book Value
| Annual Sales: | $5.2M |
|---|---|
| Cash Flow: | $-333.3K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.01 |
| Price / Book: | 15.6 |
Profitability
| EPS (TTM): | 0.39990 |
|---|---|
| Net Income (TTM): | $6.8M |
| Gross Margin: | $5M |
| Return on Equity: | 89.47% |
| Return on Assets: | 67.58% |
OpGen, Inc. Earnings Forecast
Key OpGen, Inc. Financial Ratios
-
The Gross Profit Margin over the past 12 years for OPGN is 96.00%.
-
The Selling, General & Administrative Expenses for OPGN have been equal to 90.73% of Gross Profit Margin.
-
The Research & Development expenses have been 0.94% of Revenue.
-
The Interest Expense is 0.06% of Operating Income.
-
The Net Earning history of OPGN is 230.80% of Total Revenues.
-
Per Share Earnings over the last 12 years have been positive in 10 years.
OpGen, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | OPGN |
| CUSIP: | 68373L |
| Website: | opgen.com |
Debt
| Debt-to-Equity Ratio: | 0.2 |
|---|---|
| Current Ratio: | 7.06 |
| Quick Ratio: | 5.7 |
Price-to-Earnings
| Trailing P/E Ratio: | 6.85 |
|---|---|
| Forward P/E Ratio: | 0 |
OPGN Technical Analysis vs Fundamental Analysis
Buy
63
OpGen, Inc. (OPGN)
is a Buy
Is OpGen, Inc. a Buy or a Sell?
-
OpGen, Inc. stock is rated a BuyThe current OpGen, Inc. [OPGN] share price is $15.7300. The Score for OPGN is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.